XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,615,221 | -11.3% | 164,380 | 0.0% | 0.01% | -7.7% |
| Q2 2023 | $6,328,630 | +7.6% | 164,380 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $5,883,160 | -9.2% | 164,380 | 0.0% | 0.01% | -13.3% |
| Q4 2022 | $6,481,503 | +58.2% | 164,380 | +44.9% | 0.02% | +50.0% |
| Q3 2022 | $4,096,000 | +139.3% | 113,480 | +101.6% | 0.01% | +150.0% |
| Q2 2022 | $1,712,000 | +558.5% | 56,291 | +560.7% | 0.00% | +300.0% |
| Q1 2022 | $260,000 | -77.6% | 8,520 | -77.0% | 0.00% | -50.0% |
| Q4 2021 | $1,160,000 | +140.7% | 37,115 | +17.8% | 0.00% | +100.0% |
| Q3 2021 | $482,000 | – | 31,515 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |